This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VRML Vermillion (VRML) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Vermillion Stock (NASDAQ:VRML) 30 days 90 days 365 days Advanced Chart Get Vermillion alerts:Sign Up Key Stats Today's Range$0.02▼$0.0450-Day Range$2.54▼$4.2452-Week Range$0.35▼$5.78Volume2.56 million shsAverage Volume440,144 shsMarket Capitalization$2.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.Read More… Receive VRML Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vermillion and its competitors with MarketBeat's FREE daily newsletter. Email Address VRML Stock News HeadlinesCamellia VermillionJune 16, 2023 | health.usnews.comDr. Richard L. KnutsonJune 6, 2023 | health.usnews.comTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…April 19, 2025 | Paradigm Press (Ad)Vermillion Elementary SchoolMay 24, 2023 | usnews.comDr. Kenneth J. VermillionMay 20, 2023 | health.usnews.comVermillion High SchoolMay 12, 2023 | usnews.comSanford Vermillion Medical CenterMarch 28, 2023 | health.usnews.comPREP VOLLEYBALL: North Vermillion falls in sectional opener - Yahoo NewsOctober 14, 2022 | news.yahoo.comSee More Headlines VRML Stock Analysis - Frequently Asked Questions How were Vermillion's earnings last quarter? Vermillion, Inc. (NASDAQ:VRML) released its earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share for the quarter. The company earned $1.14 million during the quarter. Vermillion had a negative net margin of 307.31% and a negative trailing twelve-month return on equity of 155.25%. What other stocks do shareholders of Vermillion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Charter Communications (CHTR), Idera Pharmaceuticals (IDRA), Magnachip Semiconductor (MX) and Cardiff Oncology (TROV). Company Calendar Last Earnings8/08/2019Today4/19/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolNASDAQ:VRML CIK926617 Webwww.vermillion.com Phone512-519-0400FaxN/AEmployees43Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,240,000.00 Net Margins-307.31% Pretax MarginN/A Return on Equity-155.25% Return on Assets-103.47% Debt Debt-to-Equity Ratio0.20 Current Ratio2.51 Quick Ratio2.49 Sales & Book Value Annual Sales$4.54 million Price / Sales0.58 Cash FlowN/A Price / Cash FlowN/A Book Value$0.09 per share Price / Book0.30Miscellaneous Outstanding Shares97,378,000Free FloatN/AMarket Cap$2.63 million OptionableNot Optionable Beta3.47 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:VRML) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vermillion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vermillion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.